Global Psychosis Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Psychosis Market Over The Period 2026–2030?

The psychosis market has demonstrated substantial growth in recent years. It is anticipated to expand from $10.46 billion in 2025 to $11.06 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.8%. The expansion observed in the past can be ascribed to several factors, including a rise in the diagnosis of schizophrenia and related disorders, the expansion of hospital-based psychiatric care facilities, the more widespread adoption of antipsychotic medications, increasing public awareness concerning mental health, and the greater availability of specialized mental health clinics.

The psychosis market size is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $13.7 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.5%. This anticipated growth during the forecast period stems from factors such as heightened investment in the creation of novel antipsychotic medications, a greater emphasis on addressing early-stage psychosis, the broadening of community-based mental health support, increasing utilization of digital therapeutic solutions, and a rising need for ongoing disease management. Key developments expected within this period include a greater deployment of long-acting injectable antipsychotics, increased embrace of early intervention initiatives, a sharper focus on integrated care approaches, the proliferation of digital tools for monitoring psychosis, and an intensified commitment to individualized treatment strategies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21266&type=smp

Which Major Factors Are Driving The Expansion Of The Psychosis Market?

A rise in mental health issues is anticipated to boost the expansion of the psychosis market in the future. These conditions encompass disorders affecting an individual’s mood, thought processes, conduct, and general psychological health. The surge in mental health cases stems from elevated stress, shifts in lifestyle, social detachment, economic strain, and inherent genetic factors. Addressing psychosis offers support to individuals with mental health challenges via timely identification, therapeutic interventions, and specialized care, resulting in a greater reliance on antipsychotic drugs and various therapeutic approaches. For example, data from May 2024, released by the American Psychiatric Association, a US-based professional body for psychiatrists and those in training, indicated that 43% of adults reported increased anxiety levels compared to the prior year, climbing from 37% in 2023 and 32% in 2022. Consequently, the growing prevalence of mental health conditions is fueling the expansion of the psychosis market.

How Is The Psychosis Market Divided Into Its Major Segments?

The psychosis market covered in this report is segmented –

1) By Product: Tablet, Capsule, Injection

2) By Disease Type: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Disease Types

3) By Distribution Channel: Online, Offline

4) By End-User: Hospitals, Healthcare Clinics, Speciality Clinics, Other End-Users

Subsegments:

1) By Tablet: Antipsychotic Tablets, Mood Stabilizer Tablets

2) By Capsule: Antipsychotic Capsules, Antidepressant Capsules

3) By Injection: Long-acting Injectable Antipsychotics, Short-acting Injectable Antipsychotics

What Key Trends Are Influencing The Development Of The Psychosis Market?

Leading entities within the psychosis market are concentrating their efforts on devising sophisticated patient-voice and data-gathering programs, aiming to refine service frameworks, guide policy choices, and foster care centered on recovery. These patient-voice endeavors allow people who have personal experience with psychosis and their relatives to communicate their requirements, difficulties, and results directly via organized questionnaires and studies, thereby facilitating advocacy based on evidence and more impactful systemic changes. An example of this is seen in November 2025, when Shine, a national mental health organization situated in Ireland, together with Mental Health Reform, an Ireland coalition dedicated to mental health, and the HSE National Clinical Programme for Early Intervention in Psychosis (EIP), introduced the 2025 National Survey of the Experiences of People Living with Psychosis. This particular program gathers direct perspectives from individuals with psychosis and their families to ascertain actual experiences encountered when seeking care, bring attention to systematic deficiencies and societal stigma, and inform enhancements in national policy, allocate funds towards specialized early intervention provisions, and broaden the availability of community-focused and crisis assistance.

Who Are The Prominent Organizations Shaping The Psychosis Market?

Major companies operating in the psychosis market are Pfizer Inc., Johnson And Johnson, AbbVie Inc., Bristol Myers Squibb Company, AstraZeneca plc, Novartis International AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Inc., Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co., Dr Reddys Laboratories Ltd., Lundbeck AS, Gedeon Richter, Alkermes, Supernus Pharmaceuticals, Acadia Pharmaceuticals, Mapi Pharma, Astellas Pharma Inc., Newron Pharmaceuticals SpA, BioXcel Therapeutics, Sun Pharmaceutical Industries Ltd., Cipla Ltd., Zydus Lifesciences Ltd.

Read the full psychosis market report here:

https://www.thebusinessresearchcompany.com/report/psychosis-global-market-report

Which Region Currently Holds The Largest Share Of The Psychosis Market?

North America was the largest region in the psychosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Psychosis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21266&type=smp

Browse Through More Reports Similar to the Global Psychosis Market 2026, By The Business Research Company

Lawn Mower Global Market Report

https://www.thebusinessresearchcompany.com/report/lawn-mower-global-market-report

Lawn Mowers Global Market Report

https://www.thebusinessresearchcompany.com/report/lawn-mowers-global-market-report

Robotic Lawn Mower Global Market Report

https://www.thebusinessresearchcompany.com/report/robotic-lawn-mower-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795